Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hanefeld

Showing results (191-200 of 224) with videos related to

Pageof 23
Sort By:
Diabetologia|May 13, 2005
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetesB Charbonnel, G Schernthaner, P Brunetti, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metalsW Leonhardt, T Kurktschiev, D Meissner, et al.
Diabetes Care|May 20, 1999
Increased intimal-medial thickness in newly detected type 2 diabetes: risk factorsT S Temelkova-Kurktschiev, C Koehler, W Leonhardt, et al.
Deutsche Medizinische Wochenschrift (1946)|November 16, 2004
[Hyperglycemia and cardiovascular events]C A Schneider, B Gallwitz, M Hanefeld, et al.
Biomedica Biochimica Acta|January 1, 1984
Fatty acid composition and action of serum lipoproteins on the PGI2-formation after various oil diets in hyperlipoproteinemiaG Honigmann, E Schimke, V Schliack, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|April 1, 1972
[Changes in metabolic parameters, especially in fat metabolism, in chronic alcoholics during clinical alcohol deficiency]W Jaross, M Hanefeld, K U Schentke, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 23, 2008
Polymorphisms in perilipin gene (PLIN) are not associated with obesity and weight variation in people with high risk of type 2 diabetesA Bergmann, J Li, M Reimann, et al.
Diabetologia|December 1, 1995
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)D Ziegler, M Hanefeld, K J Ruhnau, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1973
[Liver findings in primary hyperlipoproteinemia (HLP)]F Renger, M Hanefeld, W Jaross, et al.
Diabetes Care|September 10, 1999
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic NeuropathyD Ziegler, M Hanefeld, K J Ruhnau, et al.
Pageof 23

Showing results (191-200 of 224) with videos related to

Sort By:
Pageof 23
Diabetologia|May 13, 2005
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetesB Charbonnel, G Schernthaner, P Brunetti, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metalsW Leonhardt, T Kurktschiev, D Meissner, et al.
Diabetes Care|May 20, 1999
Increased intimal-medial thickness in newly detected type 2 diabetes: risk factorsT S Temelkova-Kurktschiev, C Koehler, W Leonhardt, et al.
Deutsche Medizinische Wochenschrift (1946)|November 16, 2004
[Hyperglycemia and cardiovascular events]C A Schneider, B Gallwitz, M Hanefeld, et al.
Biomedica Biochimica Acta|January 1, 1984
Fatty acid composition and action of serum lipoproteins on the PGI2-formation after various oil diets in hyperlipoproteinemiaG Honigmann, E Schimke, V Schliack, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|April 1, 1972
[Changes in metabolic parameters, especially in fat metabolism, in chronic alcoholics during clinical alcohol deficiency]W Jaross, M Hanefeld, K U Schentke, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 23, 2008
Polymorphisms in perilipin gene (PLIN) are not associated with obesity and weight variation in people with high risk of type 2 diabetesA Bergmann, J Li, M Reimann, et al.
Diabetologia|December 1, 1995
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)D Ziegler, M Hanefeld, K J Ruhnau, et al.
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1973
[Liver findings in primary hyperlipoproteinemia (HLP)]F Renger, M Hanefeld, W Jaross, et al.
Diabetes Care|September 10, 1999
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic NeuropathyD Ziegler, M Hanefeld, K J Ruhnau, et al.
Pageof 23